Tag: safety

Home / safety
Post

Certain Metformin diabetes drugs recalled due to the presence of NDMA

Ranbaxy Pharmaceuticals Canada Inc. is recalling six lots of its prescription RAN-Metformin drug from the Canadian market. Company testing identified two lots (#AJY8006A and #AJY8007A) with levels of NDMA above what is considered acceptable if the drug were to be taken over a lifetime. The company is recalling an additional four lots (#AJY8005A, #AJY8005B, #AJY8008A...

Post

Update on 2019-nCoV

Canada has had 4 and Ontario 3 confirmed cases as of Feb 3, 2020. This are 29 cases under investigation in Ontario. There were no cases in Peel Region. Worldwide, 17485 confirmed cases and 362 deaths have been reported to date. Airborne droplet and contact precautions are highly recommended. If you have respiratory symptoms and...

Post

Health Canada assessing NDMA in ranitidine

Health Canada is informing Canadians that it is aware that the impurity N-nitrosodimethylamine (NDMA) has been detected in some ranitidine drugs. Health Canada is closely assessing the issue in collaboration with other regulators internationally, including the U.S. Food and Drug Administration and the European Medicines Agency. The Department will take action as needed, and will keep...

Post

Opioid Use

Health Canada strengthens safety information for all opioid drugs Health Canada held a Scientific Advisory Panel on Opioid Use and Contraindications, to consider whether the current contraindications for opioid use are sufficient, or whether labelling updates and other actions may be needed to reduce risks to Canadians. After thoroughly assessing the Panel’s recommendations, Health Canada is...